Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04878172 · ClinicalTrials.gov registry record · NA
Histological Study to Assess Safety and Efficacy of the TempSure Firm for Non-Invasive Lipolysis
A NA study, sponsored by Cynosure.
- Completed
- Registry status
- NA
- Development phase
- 9
- Enrollment target
NCT04878172: Completed NA study, sponsored by Cynosure.
NCT04878172 is a NA study that has completed, run by Cynosure. The registered enrollment target is 9 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04878172, a NA study, has completed, sponsored by Cynosure.
- COMPLETED
- Registry status
- NA
- Development phase
- 9 participants
- Enrollment target
Study Summary
This is a prospective, open-labeled, non-randomized, multi-center clinical study to collect safety and efficacy data on the TempSure Firm. The intended use of the TempSure device is to use the Firm handpieces for non-invasive lipolysis.
Primary Outcome
Subjects will undergo abdominal surgery after an abdominal treatment with TempSure Firm within 24 hours post treatment. The samples were looked at from a qualitative standpoint to determine of whether the samples had signs of adipocyte injury and/or inflammatory tissue response, and if there was dermal/epidermal tissue injury (which was assessed by a qualified histologist).
Interventions
- DEVICE TempSure Firm
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2021-03-12 |
| Est. Completion | 2021-09-28 |
| Phase | NA |
What the finished NCT04878172 record still lists
NCT04878172 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 9 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which TempSure Firm is the first listed.
NCT04878172 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04878172 about?
NCT04878172 is a clinical study titled "Histological Study to Assess Safety and Efficacy of the TempSure Firm for Non-Invasive Lipolysis". This is a prospective, open-labeled, non-randomized, multi-center clinical study to collect safety and efficacy data on the TempSure Firm. The intended use of the TempSure device is to use the Firm handpieces for non-invasive lipolysis.
What is the current status of trial NCT04878172?
This trial is currently completed. It is a NA study. The enrollment target is 9 participants. The study started on 2021-03-12. Estimated completion is 2021-09-28.
What interventions are being tested in trial NCT04878172?
The interventions under investigation include: TempSure Firm (DEVICE).
Who is sponsoring clinical trial NCT04878172?
This trial is sponsored by Cynosure, which has 49 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04878172's enrollment target sits among peer trials
9 1975th of 2000 higher than 25 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI